Please login to the form below

Not currently logged in

Review: diabetes tweetchat

Some of the key points from the recent #M3diabetes tweetchat held by PMLiVE and M3 Europe

Sales reps struggle to access doctors

access deniedDoctors continue to turn away from face-to-face visits from pharma sales reps and look instead towards mobile technology for information

Research finds doctors are optimistic about new diabetes drugs but concerned over rationing

Online Physician CommunitiesNew data from M3 Global Research shows that clinicians buy in to the effectiveness of new diabetes therapies. However, they are concerned about rationing and believe that more resources are

Seven steps to innovating your digital strategy

digital numbersDealing with digitally native HCPs

Online learning increasingly popular for doctors

Online Physician CommunitiesSponsorship can help companies raise their profile specific therapy areas


UK payer perspectives: Is big data the future of market access?

'UK payer perspectives: Is big data the future of market access?’ will feature Paul Sutton, Director of Outcomes and Value, Commercial UK at Quintiles and Dr Junaid Bajwa, a GP

UK payer perspectives: the market access value paradox

'UK payer perspectives: the market access value paradox' will feature Ryan Wooller, director of market access and service innovation at Quintiles and Dr Junaid Bajwa, a GP and board member

Designing unique patient solutions in rare disease

Living with any chronic health condition can be demanding, but rare diseases bring a unique set of challenges for patients.

Unravelling the complex patient journey: can it be done?

Despite the vast progress in treatments delivered by Pharma, across multiple therapeutic areas, suboptimal patient outcomes in the real world setting remains a major concern for all stakeholders. Payers and

Country reports

Easier access to medicines in the UK?

Cutting through the NICE value-based assessment consultation to find out what’s at stake

The Chinese diabetes challenge

Marketing, communications and commercial relationships in China are full of pitfalls for the unwary, but not without great potential 

Healthcare marketing compliance in the UK - prevention beats cure

UK's MHRA gives its views on rep training, pharma advertising and social media


The impact of new technology on healthcare

Mindy Daeschner PSHealth PMLiVE speaks to Mindy Daeschner, director of healthcare technology company PSHealth.

Communiqué Awards: Andy Powrie-Smith

“Real Pharma” - key note speech at the 2013 Communiqué Awards
Andy Powrie-Smith, Director, ABPI

The effect of mobile health on patient adherence and outcomes

Think Digital 2013 Geoff McCleary PMLiVE speaks to Geoff McCleary, VP / group director, mobile innovation, Digitas Health at Think Digital 2013

White papers

The heart of the matter: Part Two

How is social media impacting publication planning?

Building Marketing Capabilities for Competitive Advantage in 2014 & Beyond: Part 2 - Future Capabilities to Build Competitive Advantage

See the industry-wide perspective on the top capabilities to build now to ensure future success for your brands.

Exploring MINT: Part 3 - Nigeria

In the third of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in Nigeria.

3 Steps to Navigating Multichannel in Healthcare

You know about multichannel, but... where now? Download the 3 Steps to Navigating Multichannel in Healthcare ebook to learn what you should do next when planning your multichannel campaign.

Featured jobs

Subscribe to our email news alerts


Add my company
Random42 Digital Healthcare Agency

Random42 is the world's premier medical animation company. Over the past 20 years we have created over 350 mechanism-of-action (MoA)...